| cytokines |
drug |
7 |
4 |
systemic cytokine |
| cytosine |
drug |
4 |
1 |
|
| Cytotune |
drug |
2 |
1 |
CytoTune™ |
| Czech Republic |
cohort |
3 |
— |
|
| D1 receptor |
drug |
5 |
5 |
D1, D1 receptor density, D1R |
| D2 receptor density |
drug |
2 |
1 |
D2 receptor |
| DA |
drug |
4 |
3 |
Dopamine, dopamine |
| DAG |
drug |
2 |
1 |
diacylglycerol |
| DAGL |
drug |
2 |
2 |
diacylglycerol lipase, α-diacylglycerol lipase, β-diacylglycerol lipase |
| DAGLA |
drug |
3 |
2 |
DAGLα, DAGL∝, diacylglycerol lipase alpha |
| DAGLα |
gene |
2 |
— |
DAGLA, Diacylglycerol lipase alpha |
| daily smoking |
phenotype |
7 |
5 |
cigarette smoking, daily smokers, daily smoking, daily smoking rates, smoked cigarettes every day for ≥1 month, smoking, smoking on all of the past 30 days, tobacco smoking |
| D allele |
variant |
3 |
3 |
D, d |
| DALRD3 |
gene |
2 |
2 |
DALR Anticodon Binding Domain Containing 3, DALR anticodon binding domain containing 3 |
| damaging variants |
variant |
2 |
2 |
de novo damaging variants, deleterious variants |
| DAMGO |
drug |
5 |
5 |
D-Ala2-MePhe4-Gly-ol5-enkephalin, [3H]-D-Ala2, N-MePhe4, Gly-ol]-enkephalin, [D-Ala 2, N-MePhe4, Gly-ol]-enkephalin, [D-Ala2, N-MePhe4, Gly-ol]-enkephalin, [D-Ala2,N-MePhe4,Gly-ol5]-enkephalin |
| d-amphetamine |
drug |
3 |
2 |
AMP |
| DAMPs |
drug |
3 |
3 |
damage-associated molecular patterns |
| Danio rerio |
cohort |
5 |
2 |
DANRE, zebrafish |
| Danish Twin Registry |
cohort |
2 |
2 |
DTR |
